Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 5.49
+0.26 (4.97%)
Nov 10, 2026, 1:31 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 2.35 billion as of November 9, 2026. It is the 27,348th most valuable company in the world and the 1,520th biggest in Taiwan. Its market cap has decreased by 41.25% in one year.
Market Cap
2.35B
Enterprise Value
2.25B
Revenue
n/a
Global Rank
Country Rank
#1,520 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 2.35B, a decrease of -54.00%. That is a compound annual growth rate of -18.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 2.32B | -33.26% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 4.23B |
| Yoda Pharmaceuticals | 4.04B |
| Orient EuroPharma | 3.67B |
| Easywell Biomedicals | 3.15B |
| Maywufa Company | 2.77B |
| Allied Biotech | 2.56B |
| TSH Biopharm Corporation | 2.36B |
| PhytoHealth | 2.11B |